| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 29 | 2018 | 9979 | 0.670 |
Why?
|
| Chemokines, CC | 6 | 2007 | 283 | 0.600 |
Why?
|
| Hypertension, Pulmonary | 9 | 2022 | 1585 | 0.480 |
Why?
|
| Retinoids | 1 | 2012 | 99 | 0.390 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2012 | 461 | 0.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 2518 | 0.320 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2013 | 820 | 0.320 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 355 | 0.320 |
Why?
|
| Smoking | 4 | 2012 | 9055 | 0.280 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2007 | 301 | 0.250 |
Why?
|
| Asthma | 9 | 2011 | 6229 | 0.250 |
Why?
|
| Cytokines | 13 | 2004 | 7386 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2892 | 0.220 |
Why?
|
| Receptors, Neurokinin-2 | 2 | 2001 | 24 | 0.200 |
Why?
|
| Angiopoietins | 1 | 2002 | 86 | 0.200 |
Why?
|
| MicroRNAs | 5 | 2015 | 3758 | 0.190 |
Why?
|
| Neurokinin A | 1 | 2001 | 32 | 0.190 |
Why?
|
| Bronchoalveolar Lavage Fluid | 8 | 2004 | 753 | 0.190 |
Why?
|
| Growth Substances | 1 | 2002 | 759 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 3598 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 672 | 0.170 |
Why?
|
| Signal Transduction | 6 | 2021 | 23415 | 0.170 |
Why?
|
| Extracellular Matrix | 3 | 2016 | 1720 | 0.170 |
Why?
|
| Pulmonary Surfactants | 4 | 2006 | 162 | 0.170 |
Why?
|
| Phosphoproteins | 3 | 2018 | 2443 | 0.170 |
Why?
|
| Lymphokines | 1 | 2002 | 925 | 0.160 |
Why?
|
| Chemokine CCL11 | 6 | 2007 | 128 | 0.160 |
Why?
|
| Collagen Type III | 2 | 2018 | 91 | 0.160 |
Why?
|
| Iron-Sulfur Proteins | 2 | 2019 | 83 | 0.160 |
Why?
|
| Respiratory Mucosa | 4 | 2002 | 436 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2014 | 1650 | 0.150 |
Why?
|
| Receptors, Chemokine | 2 | 2002 | 654 | 0.150 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 737 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2016 | 528 | 0.150 |
Why?
|
| Epithelial Cells | 9 | 2013 | 3666 | 0.150 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2001 | 283 | 0.150 |
Why?
|
| Fetus | 4 | 2012 | 1862 | 0.150 |
Why?
|
| Methacholine Chloride | 2 | 2011 | 220 | 0.140 |
Why?
|
| Eosinophils | 4 | 2007 | 951 | 0.140 |
Why?
|
| Gene Regulatory Networks | 3 | 2015 | 1744 | 0.140 |
Why?
|
| Mice | 35 | 2021 | 81324 | 0.140 |
Why?
|
| Neurosecretory Systems | 1 | 1998 | 223 | 0.140 |
Why?
|
| Lung Diseases | 3 | 2002 | 1909 | 0.140 |
Why?
|
| Vasculitis | 1 | 2000 | 522 | 0.130 |
Why?
|
| Chromogranins | 1 | 1997 | 160 | 0.130 |
Why?
|
| Thiolester Hydrolases | 1 | 1997 | 90 | 0.130 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1056 | 0.130 |
Why?
|
| Carcinoma, Small Cell | 1 | 1998 | 420 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2870 | 0.130 |
Why?
|
| RNA, Messenger | 16 | 2012 | 12743 | 0.130 |
Why?
|
| Glycine | 1 | 2019 | 659 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2004 | 4340 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1301 | 0.120 |
Why?
|
| Receptors, CCR3 | 2 | 2007 | 62 | 0.120 |
Why?
|
| Hypersensitivity | 2 | 2002 | 1167 | 0.120 |
Why?
|
| Sulfur | 1 | 2015 | 160 | 0.120 |
Why?
|
| Chemokines | 2 | 2002 | 956 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 15 | 2019 | 22129 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3090 | 0.120 |
Why?
|
| Animals | 45 | 2021 | 168083 | 0.120 |
Why?
|
| Bronchi | 5 | 2006 | 843 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 1488 | 0.110 |
Why?
|
| Fibrosis | 2 | 2018 | 2051 | 0.110 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2004 | 48 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 1312 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 974 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 475 | 0.110 |
Why?
|
| Graft Rejection | 5 | 2004 | 4479 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3696 | 0.100 |
Why?
|
| Immunohistochemistry | 12 | 2006 | 11066 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 15915 | 0.100 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2014 | 204 | 0.100 |
Why?
|
| Cotinine | 1 | 2012 | 206 | 0.100 |
Why?
|
| Proteolipids | 2 | 2002 | 113 | 0.100 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 224 | 0.100 |
Why?
|
| Mice, Inbred Strains | 3 | 2004 | 1761 | 0.090 |
Why?
|
| Pulmonary Alveoli | 3 | 2014 | 651 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 307 | 0.090 |
Why?
|
| Cells, Cultured | 11 | 2021 | 18926 | 0.090 |
Why?
|
| Bronchoconstriction | 3 | 2006 | 141 | 0.090 |
Why?
|
| Transcription Factors | 6 | 2016 | 12096 | 0.090 |
Why?
|
| Muscle, Smooth | 3 | 2004 | 927 | 0.090 |
Why?
|
| Maternal Behavior | 1 | 2012 | 307 | 0.090 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 699 | 0.090 |
Why?
|
| Leukocytes | 1 | 1998 | 2024 | 0.090 |
Why?
|
| Progesterone | 1 | 2014 | 742 | 0.090 |
Why?
|
| Cilia | 1 | 2013 | 491 | 0.080 |
Why?
|
| Gene Expression | 6 | 2011 | 7567 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 716 | 0.080 |
Why?
|
| Pregnancy | 8 | 2012 | 29872 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 1998 | 1885 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3577 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2002 | 4933 | 0.080 |
Why?
|
| Chemokine CCL24 | 1 | 2007 | 8 | 0.080 |
Why?
|
| Cell Count | 3 | 2002 | 1831 | 0.080 |
Why?
|
| Models, Animal | 5 | 2021 | 2114 | 0.070 |
Why?
|
| Endothelial Cells | 5 | 2021 | 3550 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2571 | 0.070 |
Why?
|
| Estradiol | 1 | 2014 | 1936 | 0.070 |
Why?
|
| Phosphatidylglycerols | 1 | 2006 | 34 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4421 | 0.070 |
Why?
|
| Ovalbumin | 3 | 2004 | 671 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2004 | 2200 | 0.070 |
Why?
|
| Guinea Pigs | 5 | 2002 | 1309 | 0.070 |
Why?
|
| Mice, Knockout | 10 | 2013 | 14393 | 0.070 |
Why?
|
| Blotting, Northern | 4 | 2001 | 1544 | 0.070 |
Why?
|
| Pneumonia | 3 | 2007 | 2142 | 0.070 |
Why?
|
| Fibrinolysin | 1 | 2006 | 130 | 0.070 |
Why?
|
| Plasminogen | 1 | 2006 | 143 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2014 | 4111 | 0.060 |
Why?
|
| Gene Expression Profiling | 5 | 2006 | 9416 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2018 | 8164 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1326 | 0.060 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2015 | 118 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 3200 | 0.060 |
Why?
|
| Bronchial Provocation Tests | 2 | 2004 | 216 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 613 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4565 | 0.060 |
Why?
|
| Trachea | 4 | 2013 | 1090 | 0.060 |
Why?
|
| Heart Transplantation | 3 | 2004 | 3258 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2004 | 43 | 0.060 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2004 | 29 | 0.060 |
Why?
|
| Lung Neoplasms | 4 | 2014 | 13382 | 0.060 |
Why?
|
| Cell Line | 5 | 2012 | 15542 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2802 | 0.060 |
Why?
|
| Rats | 7 | 2018 | 23713 | 0.060 |
Why?
|
| Graft Survival | 3 | 2004 | 3841 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2014 | 10421 | 0.050 |
Why?
|
| Placenta | 1 | 2012 | 1709 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 563 | 0.050 |
Why?
|
| Interleukin-13 | 2 | 2004 | 392 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2004 | 169 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 908 | 0.050 |
Why?
|
| Gestational Age | 2 | 2012 | 3577 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2001 | 134 | 0.050 |
Why?
|
| Female | 22 | 2022 | 392458 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 11856 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 17 | 0.050 |
Why?
|
| Capsaicin | 2 | 2001 | 232 | 0.050 |
Why?
|
| Collectins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2006 | 1463 | 0.050 |
Why?
|
| Apoproteins | 1 | 2002 | 44 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.050 |
Why?
|
| Bombesin | 2 | 1999 | 35 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2004 | 563 | 0.050 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2802 | 0.050 |
Why?
|
| Angiopoietin-1 | 1 | 2002 | 122 | 0.050 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2001 | 48 | 0.050 |
Why?
|
| PPAR gamma | 2 | 2015 | 483 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 346 | 0.050 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 18217 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 1999 | 11505 | 0.050 |
Why?
|
| Peroxidases | 1 | 2002 | 134 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.050 |
Why?
|
| Barium Compounds | 1 | 2001 | 18 | 0.050 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 872 | 0.050 |
Why?
|
| Humans | 37 | 2022 | 761098 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2004 | 618 | 0.050 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2001 | 77 | 0.050 |
Why?
|
| Male | 24 | 2022 | 360675 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 444 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 145 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 698 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.050 |
Why?
|
| Mast Cells | 2 | 2000 | 1392 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2002 | 4008 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2340 | 0.040 |
Why?
|
| Immunization | 2 | 2002 | 1218 | 0.040 |
Why?
|
| Transcription, Genetic | 4 | 2004 | 7574 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2005 | 1111 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2002 | 271 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3776 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2007 | 906 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2002 | 524 | 0.040 |
Why?
|
| Antibody Formation | 2 | 2002 | 1391 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 1443 | 0.040 |
Why?
|
| Computational Biology | 1 | 2012 | 3499 | 0.040 |
Why?
|
| Peptides | 3 | 2001 | 4353 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 585 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 282 | 0.040 |
Why?
|
| Trans-Activators | 3 | 2016 | 2846 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2004 | 1435 | 0.040 |
Why?
|
| Professional-Family Relations | 1 | 2003 | 495 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2002 | 773 | 0.040 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 1998 | 36 | 0.040 |
Why?
|
| Patient Care Planning | 2 | 2003 | 904 | 0.040 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 1998 | 27 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2004 | 1480 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2019 | 201 | 0.040 |
Why?
|
| Perfusion | 2 | 2001 | 1390 | 0.040 |
Why?
|
| Nitrosamines | 1 | 1998 | 87 | 0.040 |
Why?
|
| Chlorides | 1 | 2001 | 657 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2001 | 348 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 11701 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3536 | 0.040 |
Why?
|
| Stem Cells | 1 | 2011 | 3512 | 0.040 |
Why?
|
| Calcitonin | 1 | 1999 | 329 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2018 | 166 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1231 | 0.040 |
Why?
|
| Cathepsins | 1 | 1999 | 241 | 0.040 |
Why?
|
| Communication | 2 | 2003 | 3852 | 0.040 |
Why?
|
| Pulmonary Artery | 2 | 2018 | 1927 | 0.040 |
Why?
|
| Chromogranin A | 1 | 1997 | 47 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1682 | 0.040 |
Why?
|
| Allergens | 2 | 2002 | 1433 | 0.030 |
Why?
|
| Genes, ras | 1 | 1999 | 654 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1998 | 258 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 2656 | 0.030 |
Why?
|
| Mesoderm | 1 | 1999 | 673 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2000 | 941 | 0.030 |
Why?
|
| Bronchitis | 1 | 1997 | 196 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1999 | 1150 | 0.030 |
Why?
|
| Germinal Center | 1 | 1999 | 380 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2001 | 1178 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 573 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1999 | 1607 | 0.030 |
Why?
|
| Fetal Heart | 1 | 1996 | 281 | 0.030 |
Why?
|
| Benzylamines | 1 | 2015 | 247 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2006 | 696 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1837 | 0.030 |
Why?
|
| Cricetinae | 1 | 1998 | 2412 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 4 | 2004 | 6198 | 0.030 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1998 | 326 | 0.030 |
Why?
|
| Systems Theory | 1 | 2014 | 57 | 0.030 |
Why?
|
| Benzoates | 1 | 2015 | 211 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2000 | 1096 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2002 | 2203 | 0.030 |
Why?
|
| Acute Disease | 2 | 2002 | 7240 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6123 | 0.030 |
Why?
|
| Substance P | 1 | 1995 | 334 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1997 | 455 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1996 | 519 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 2 | 2004 | 30 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 221 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17889 | 0.030 |
Why?
|
| Histamine | 1 | 1995 | 499 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2046 | 0.030 |
Why?
|
| Interleukin-1 | 3 | 2002 | 1250 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 864 | 0.030 |
Why?
|
| Cluster Analysis | 3 | 2006 | 2706 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2227 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 471 | 0.030 |
Why?
|
| Nitric Oxide | 2 | 2004 | 2135 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2012 | 89 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 475 | 0.030 |
Why?
|
| Interleukin-4 | 3 | 2002 | 1154 | 0.030 |
Why?
|
| Compressive Strength | 2 | 2004 | 158 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2003 | 3743 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9566 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2012 | 452 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 588 | 0.020 |
Why?
|
| Length of Stay | 2 | 2003 | 6420 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2003 | 5296 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2004 | 1083 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 505 | 0.020 |
Why?
|
| Mucus | 1 | 2013 | 342 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2007 | 660 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 944 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 244 | 0.020 |
Why?
|
| Adult | 9 | 2022 | 221083 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 3493 | 0.020 |
Why?
|
| Child | 3 | 2019 | 80134 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2007 | 10203 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 3803 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 371 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Chemotactic Factors, Eosinophil | 2 | 2001 | 40 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2021 | 2477 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 883 | 0.020 |
Why?
|
| Cell Lineage | 1 | 1999 | 2547 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1756 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 872 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3409 | 0.020 |
Why?
|
| Interferon-gamma | 3 | 2004 | 3155 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2003 | 3238 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1998 | 2475 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2003 | 4822 | 0.020 |
Why?
|
| Benzamides | 1 | 1995 | 1370 | 0.020 |
Why?
|
| Monocytes | 1 | 1998 | 2570 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1283 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1676 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1004 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 4744 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 773 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1074 | 0.020 |
Why?
|
| Interleukins | 2 | 2004 | 782 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1138 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1133 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2635 | 0.020 |
Why?
|
| Phenotype | 2 | 2013 | 16572 | 0.020 |
Why?
|
| Critical Care | 1 | 2000 | 2690 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2666 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1667 | 0.020 |
Why?
|
| Middle Aged | 6 | 2022 | 220835 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 726 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1318 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 9518 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 5775 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 4405 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 75 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1900 | 0.020 |
Why?
|
| Piperidines | 1 | 1995 | 1656 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
| Protease Nexins | 1 | 2005 | 39 | 0.020 |
Why?
|
| Serpin E2 | 1 | 2005 | 48 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3591 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1994 | 2197 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9300 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2019 | 42217 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 36164 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1967 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 88271 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 914 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2006 | 325 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 1932 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 278 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 6224 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 600 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2004 | 190 | 0.020 |
Why?
|
| Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3582 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 31 | 0.010 |
Why?
|
| Surface Tension | 1 | 2004 | 43 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2004 | 39 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 792 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 74219 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2004 | 221 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 459 | 0.010 |
Why?
|
| Serum Response Factor | 1 | 2004 | 78 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2003 | 94 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2004 | 133 | 0.010 |
Why?
|
| Antigens | 2 | 2002 | 1441 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 249 | 0.010 |
Why?
|
| Models, Biological | 2 | 2014 | 9455 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2004 | 329 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2004 | 140 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 196 | 0.010 |
Why?
|
| Heart | 1 | 1996 | 4431 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 631 | 0.010 |
Why?
|
| Phospholipids | 1 | 2006 | 784 | 0.010 |
Why?
|
| Inflammation | 2 | 2004 | 10758 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 517 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1994 | 3422 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1600 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2002 | 145 | 0.010 |
Why?
|
| Kinetics | 2 | 2002 | 6312 | 0.010 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5195 | 0.010 |
Why?
|
| Regeneration | 1 | 2011 | 1505 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2815 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2004 | 8303 | 0.010 |
Why?
|
| Homozygote | 1 | 2006 | 1775 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2002 | 137 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2002 | 314 | 0.010 |
Why?
|
| Aerosols | 1 | 2004 | 635 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 296 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2001 | 5033 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 575 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 266 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 59199 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 577 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 255 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 1075 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6225 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 242 | 0.010 |
Why?
|
| Patient Care Team | 2 | 2003 | 2513 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1597 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1487 | 0.010 |
Why?
|
| APACHE | 1 | 2000 | 267 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1520 | 0.010 |
Why?
|
| Syntaxin 1 | 1 | 1999 | 29 | 0.010 |
Why?
|
| Choline | 1 | 2001 | 515 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 317 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 30006 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 2714 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 597 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 823 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 793 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2002 | 469 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1176 | 0.010 |
Why?
|
| Time Factors | 4 | 2003 | 39953 | 0.010 |
Why?
|
| Skin Tests | 1 | 2001 | 638 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 3700 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1999 | 145 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4922 | 0.010 |
Why?
|
| Flavonoids | 1 | 2002 | 444 | 0.010 |
Why?
|
| Case Management | 1 | 2000 | 272 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2003 | 1042 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 420 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 696 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 838 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2003 | 1071 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2004 | 1505 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1999 | 317 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2001 | 890 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 1351 | 0.010 |
Why?
|
| Chimera | 1 | 1999 | 453 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1998 | 212 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 2902 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14676 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 818 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1240 | 0.010 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1999 | 289 | 0.010 |
Why?
|
| Vagotomy | 1 | 1997 | 83 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3266 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1696 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7513 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1998 | 272 | 0.010 |
Why?
|
| Palliative Care | 2 | 2003 | 3593 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 3430 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2002 | 2621 | 0.010 |
Why?
|
| Papio | 1 | 1998 | 669 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 260 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 2692 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15308 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 1997 | 167 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 1750 | 0.010 |
Why?
|
| Pyrilamine | 1 | 1995 | 13 | 0.010 |
Why?
|
| Catecholamines | 1 | 1996 | 387 | 0.010 |
Why?
|
| Receptors, Histamine | 1 | 1995 | 23 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12404 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2001 | 909 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6067 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22157 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 5750 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 3665 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 1999 | 1559 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 3210 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5478 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2001 | 2603 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1157 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80673 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 1963 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 1251 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 2562 | 0.010 |
Why?
|
| Health Services Research | 1 | 2000 | 1807 | 0.010 |
Why?
|
| Neuroendocrine Tumors | 1 | 1999 | 641 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 2290 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 4137 | 0.010 |
Why?
|
| Cell Separation | 1 | 1998 | 1718 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 4451 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4510 | 0.010 |
Why?
|
| Aged | 3 | 2016 | 169266 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 1999 | 6340 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2708 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1997 | 944 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 17598 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10755 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2002 | 4372 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 9648 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2000 | 10083 | 0.000 |
Why?
|
| Dendritic Cells | 1 | 1999 | 2726 | 0.000 |
Why?
|
| Boston | 1 | 2000 | 9324 | 0.000 |
Why?
|
| Massachusetts | 1 | 2000 | 8836 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1998 | 26187 | 0.000 |
Why?
|
| Oxygen | 1 | 1998 | 4226 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12467 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13254 | 0.000 |
Why?
|
| Radiography | 1 | 1994 | 6975 | 0.000 |
Why?
|
| Myocardium | 1 | 1996 | 4746 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 15845 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1997 | 9317 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39121 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 9185 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2003 | 41486 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13630 | 0.000 |
Why?
|
| Neurons | 1 | 1996 | 9435 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 54419 | 0.000 |
Why?
|
| United States | 1 | 2003 | 72337 | 0.000 |
Why?
|